Iterum Therapeutics Plc (NASDAQ: ITRM) reported Q4 EPS of ($0.11), $0.08 better than the analyst estimate of ($0.19).

For earnings history and earnings-related data on Iterum Therapeutics Plc (ITRM) click here.